8th Annual Pricing, Reimbursement & Market Access
Organization: Fleming Europe
|Event Date/Time: Jan 17, 2013||End Date/Time: Jan 18, 2013|
Pharmaceutical pricing, reimbursement and market access systems differ significantly in the European countries and are regularly subject to change. Our aim is to provide an overview about pharmaceutical pricing and reimbursement policies, their application, obstacles and opportunities within the industry and national systems. Reference pricing initiatives applied to innovative drugs, austerity measures influence on healthcare delivery and long market access periods present challenges, which can be more managable by multi-stakeholders discussions in a highly proactive environment. Following seven successful annual events, Fleming Europe invites you to the 8th Annual Pricing, Reimbursement & Market Access in Pharma.
Yet again, we are going to benchmark the recent policy developmentsand best practices in P&Racross major European markets to ensure smoother access of patients to new medicines. At this conference, you will have the chance to meet global market leaders, top speakers and professionals with superior expertise from the pharmaceutical industry, HTAs, academia and patient groups.